Cargando…
Higher percentage of CD133(+ )cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
BACKGROUND: Cancer stem cell model suggested that tumor progression is driven by the overpopulation of cancer stem cells and eradicating or inhibiting the symmetric division of cancer stem cells would become the most important therapeutic strategy. However, clinical evidence for this hypothesis is s...
Autores principales: | Li, Chun-Yan, Li, Bao-Xiu, Liang, Yi, Peng, Rui-Qing, Ding, Ya, Xu, Da-Zhi, Zhang, Xin, Pan, Zhi-Zhong, Wan, De-Sen, Zeng, Yi-Xin, Zhu, Xiao-Feng, Zhang, Xiao-Shi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715381/ https://www.ncbi.nlm.nih.gov/pubmed/19583834 http://dx.doi.org/10.1186/1479-5876-7-56 |
Ejemplares similares
-
Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer
por: Peng, Rui-Qing, et al.
Publicado: (2010) -
CD133(+)CXCR4(+ )colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
por: Zhang, Shan-shan, et al.
Publicado: (2012) -
Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020) -
No relationship between the distribution of mast cells and the survival of stage IIIB colon cancer patients
por: Xia, Qing, et al.
Publicado: (2011) -
Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer
por: Xin, Bing, et al.
Publicado: (2019)